Jason Miska

4.3k total citations · 4 hit papers
73 papers, 2.8k citations indexed

About

Jason Miska is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jason Miska has authored 73 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Immunology, 27 papers in Oncology and 24 papers in Molecular Biology. Recurrent topics in Jason Miska's work include Immune cells in cancer (22 papers), Immunotherapy and Immune Responses (19 papers) and Glioma Diagnosis and Treatment (18 papers). Jason Miska is often cited by papers focused on Immune cells in cancer (22 papers), Immunotherapy and Immune Responses (19 papers) and Glioma Diagnosis and Treatment (18 papers). Jason Miska collaborates with scholars based in United States, Germany and Mexico. Jason Miska's co-authors include Maciej S. Lesniak, Yu Han, Aida Rashidi, Atique U. Ahmed, Deepak Kanojia, Navdeep S. Chandel, Catalina Lee-Chang, Peng Zhang, Craig Horbinski and Aurora Lopez‐Rosas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Jason Miska

66 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells

2016 479 citations Alan L. Chang, Jason Miska et al. Cancer Research profile →
Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation

2022 216 citations Leah K. Billingham, Joshua S. Stoolman et al. Nature Immunology profile →
STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma

2023 139 citations Peng Zhang, Aida Rashidi et al. Nature Communications profile →
Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression

2024 70 citations Fatima Khan, Yiyun Lin et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jason Miska United States	27	1.4k	1.1k	897	623	486	73	2.8k
Deepak Kanojia United States	22	579 0.4×	773 0.7×	788 0.9×	360 0.6×	292 0.6×	48	1.9k
Lin Cheng China	25	465 0.3×	1.9k 1.8×	990 1.1×	747 1.2×	784 1.6×	75	3.4k
Catalina Lee-Chang United States	21	1.1k 0.8×	526 0.5×	739 0.8×	375 0.6×	271 0.6×	45	2.0k
Tiziana Annese Italy	30	548 0.4×	1.7k 1.6×	800 0.9×	211 0.3×	772 1.6×	99	3.2k
Yanqing Gong United States	19	484 0.4×	771 0.7×	480 0.5×	333 0.5×	473 1.0×	35	1.7k
Ichiro Nakano United States	28	504 0.4×	1.9k 1.8×	798 0.9×	461 0.7×	738 1.5×	34	2.8k
Géza Sáfrány Hungary	27	437 0.3×	777 0.7×	489 0.5×	270 0.4×	291 0.6×	75	2.0k
Michael Y. Choi United States	28	555 0.4×	1.2k 1.2×	711 0.8×	1.1k 1.7×	303 0.6×	114	2.9k
Johan Lennartsson Sweden	31	880 0.6×	1.8k 1.7×	715 0.8×	367 0.6×	321 0.7×	76	3.5k
Sergey V. Novitskiy United States	29	1.6k 1.2×	1.6k 1.5×	1.6k 1.8×	103 0.2×	665 1.4×	51	4.0k

Countries citing papers authored by Jason Miska

Since Specialization

Citations

This map shows the geographic impact of Jason Miska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Miska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Miska more than expected).

Fields of papers citing papers by Jason Miska

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Miska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Miska. The network helps show where Jason Miska may publish in the future.

Co-authorship network of co-authors of Jason Miska

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Miska. A scholar is included among the top collaborators of Jason Miska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Miska. Jason Miska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Seung‐Hyun, Lisa Hurley, Serena Tommasini-Ghelfi, et al.. (2025). cGAS-agonistic spherical nucleic acids reprogram the glioblastoma immune microenvironment and promote antitumor immunity. Proceedings of the National Academy of Sciences. 122(45). e2409557122–e2409557122.

Stoolman, Joshua S., Rogan A. Grant, Leah K. Billingham, et al.. (2025). Mitochondria complex III–generated superoxide is essential for IL-10 secretion in macrophages. Science Advances. 11(4). eadu4369–eadu4369. 12 indexed citations

Panek, Wojciech K., Ryan G. Toedebusch, Bridget McLaughlin, et al.. (2024). The CCL2-CCR4 axis promotes Regulatory T cell trafficking to canine glioma tissues. Journal of Neuro-Oncology. 169(3). 647–658. 4 indexed citations

Chen, Xiaoyang, et al.. (2024). It Is Not Just About Storing Energy: The Multifaceted Role of Creatine Metabolism on Cancer Biology and Immunology. International Journal of Molecular Sciences. 25(24). 13273–13273. 2 indexed citations

Boland, Lauren, Slim Fourati, Chao Wei, et al.. (2024). DIPG-32. NEOANTIGEN HEAT SHOCK PROTEIN VACCINE, RHSC-DIPGVAX, IS ASSOCIATED WITH INCREASED VACCINE-INDUCED B CELLS AND BCR/TCR REPERTOIRE DIVERSITY IN PEDIATRIC PATIENTS WITH DIFFUSE MIDLINE GLIOMAS. Neuro-Oncology. 26(Supplement_4). 0–0. 1 indexed citations

Khan, Fatima, Yiyun Lin, Heba Ali, et al.. (2024). Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression. Nature Communications. 15(1). 1987–1987. 70 indexed citations breakdown →

Arrieta, Víctor A., Jasim Kada Benotmane, Junfei Zhao, et al.. (2024). Characterization of Immune Cell Heterogeneity, Key B Cell Subtypes, and Macrophages Functions Using Multiplex Immunofluorescence and Single-cell RNA Sequencing in Chordomas. Neurosurgery. 70(Supplement_1). 202–203.

Fares, Jawad, Crismita Dmello, Peng Zhang, et al.. (2023). Endoplasmic Reticulum Stress in the Brain Tumor Immune Microenvironment. Molecular Cancer Research. 21(5). 389–396. 4 indexed citations

Billingham, Leah K., Joshua S. Stoolman, Karthik Vasan, et al.. (2022). Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation. Nature Immunology. 23(5). 692–704. 216 indexed citations breakdown →

10.

Shireman, Jack, Fatemeh Atashi, Gina Lee, et al.. (2021). De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma. Brain. 144(4). 1230–1246. 46 indexed citations

11.

Miska, Jason, Aida Rashidi, Catalina Lee-Chang, et al.. (2021). Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma. Science Advances. 7(8). 75 indexed citations

12.

Lee-Chang, Catalina, Jason Miska, David Hou, et al.. (2020). Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma. The Journal of Experimental Medicine. 218(1). 49 indexed citations

13.

Lee-Chang, Catalina, Aida Rashidi, Jason Miska, et al.. (2019). Myeloid-Derived Suppressive Cells Promote B cell–Mediated Immunosuppression via Transfer of PD-L1 in Glioblastoma. Cancer Immunology Research. 7(12). 1928–1943. 120 indexed citations

14.

Pituch, Katarzyna C., Jason Miska, Giedre Krenciute, et al.. (2018). Adoptive Transfer of IL13Rα2-Specific Chimeric Antigen Receptor T Cells Creates a Pro-inflammatory Environment in Glioblastoma. Molecular Therapy. 26(4). 986–995. 67 indexed citations

15.

Muroski, Megan E., Jason Miska, Alan L. Chang, et al.. (2017). Fatty Acid Uptake in T Cell Subsets Using a Quantum Dot Fatty Acid Conjugate. Scientific Reports. 7(1). 5790–5790. 26 indexed citations

16.

Kim, Julius W., Jason Miska, Jacob S. Young, et al.. (2017). A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model. Molecular Therapy — Oncolytics. 5. 97–104. 16 indexed citations

17.

Chang, Alan L., Jason Miska, Derek A. Wainwright, et al.. (2016). CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells. Cancer Research. 76(19). 5671–5682. 479 indexed citations breakdown →

18.

Kanojia, Deepak, Ramin A. Morshed, Lingjiao Zhang, et al.. (2015). βIII-Tubulin Regulates Breast Cancer Metastases to the Brain. Molecular Cancer Therapeutics. 14(5). 1152–1161. 42 indexed citations

19.

Miska, Jason & Maciej S. Lesniak. (2015). Neural Stem Cell Carriers for the Treatment of Glioblastoma Multiforme. EBioMedicine. 2(8). 774–775. 17 indexed citations

20.

Qiao, Jian, Mahua Dey, Alan L. Chang, et al.. (2015). Intratumoral oncolytic adenoviral treatment modulates the glioma microenvironment and facilitates systemic tumor-antigen-specific T cell therapy. OncoImmunology. 4(8). e1022302–e1022302. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact